EcoDrugPlus

Ensembl ID : YER102W
Description: -
114 Possible Orthologues:

Title

Ensembl ID : YER117W
Description: -
117 Possible Orthologues:

Title

Ensembl ID : YER123W
Description: -
633 Possible Orthologues:

Title

Ensembl ID : YER131W
Description: -
97 Possible Orthologues:

Title

Ensembl ID : YFL037W
Description: -
159 Possible Orthologues:

Title

Ensembl ID : YFR004W
Description: -
78 Possible Orthologues:

Title

Ensembl ID : YFR031C-A
Description: -
195 Possible Orthologues:

Title

Ensembl ID : YFR032C-A
Description: -
78 Possible Orthologues:

Title

Ensembl ID : YFR050C
Description: -
74 Possible Orthologues:

Title

Ensembl ID : YFR052W
Description: -
75 Possible Orthologues:

Title

Ensembl ID : YFR053C
Description: -
80 Possible Orthologues:

Title

Ensembl ID : YGL008C
Description: -
1082 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).